Your session is about to expire
← Back to Search
tDCS + CILT for Aphasia
Study Summary
This trial will test the effect of combining two therapies, constraint-induced language therapy and cerebellar tDCS, to see if it improves language skills in adults with non-fluent aphasia after a stroke.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I have a history of migraines.I have psoriasis or eczema on my scalp.You have any metal implants in your body, except for dental fillings.I have reliable means to get to my appointments.I have a history of seizures.I have had a stroke in the past.I have been diagnosed with difficulty in forming words or sentences.I am over 18 years old.You have had a head injury like a concussion in the past.I have been diagnosed with a mental health or neurological condition.I have had a stroke in the past.I have been diagnosed with a speech disorder affecting my fluency.I can communicate using speech.
- Group 1: Sham tDCS
- Group 2: Real tDCS
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Are there any slots remaining for patients to join this scientific trial?
"The information provided on clinicaltrials.gov shows that this specific study is no longer taking in enrolments, as its last update was registered 11/8/2022 - it originally began recruiting volunteers on 1/25/2023. However, 1376 other studies are still open for participant recruitment."
What goals are this clinical experiment striving to attain?
"The primary focus of this study is to conduct a Discourse Analysis on Picture Description. Secondary metrics that are being monitored include Working Memory (measured using the Wisconsin Card Sorting Test), EEG: Peak Alpha Frequency, and Stroke Aphasia Quality of Life (SA-QOL). The scores for these outcomes will be tracked over two weeks after the second baseline visit; higher values indicate better performance."
Who else is applying?
What state do they live in?
What site did they apply to?
What portion of applicants met pre-screening criteria?
How many prior treatments have patients received?
Why did patients apply to this trial?
How responsive is this trial?
Typically responds via
Most responsive sites:
- University of Minnesota: < 48 hours
Average response time
- < 2 Days
Share this study with friends
Copy Link
Messenger